rss

Author index

September 1998, Volume 53, Issue 9

[Front cover][Table of contents]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. ALONSO, JORDI

    • Comparison of outcome measures in patients with COPD
      1. Commentator:
        • ROSEMARY HARPER,
        • JOHN BRAZIER,
        • and JUDITH WATERHOUSE
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813

  2. ANTÓ, JOSEP M

    • Comparison of outcome measures in patients with COPD
      1. Commentator:
        • ROSEMARY HARPER,
        • JOHN BRAZIER,
        • and JUDITH WATERHOUSE
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813

B

  1. Ballmann, Manfred

    • Long term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosacolonisation in patients with cystic fibrosis Thorax 1998;53:9 732-737 doi:10.1136/thx.53.9.732

  2. Barnes, P J

    • Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis Thorax 1998;53:9 775-779 doi:10.1136/thx.53.9.775

  3. BAUDOUIN, S V

    • Respiratory intensive care in Europe: lessons for the UK Thorax 1998;53:9 725-726 doi:10.1136/thx.53.9.725

  4. Beghé, Bianca

    • Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease Thorax 1998;53:9 803-808 doi:10.1136/thx.53.9.803

  5. Bisson, S

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

  6. Boothman-Burrell, David

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  7. BRAZIER, JOHN

    • Comparison of outcome measures in patients with COPD
      1. Commentator:
        • ROSEMARY HARPER,
        • JOHN BRAZIER,
        • and JUDITH WATERHOUSE
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813

  8. Burge, P S

    • Effect of the number of peak expiratory flow readings per day on the estimation of diurnal variation Thorax 1998;53:9 790-792 doi:10.1136/thx.53.9.790

  9. Burke, Conor M

    • Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time Thorax 1998;53:9 753-761 doi:10.1136/thx.53.9.753

C

  1. CALVERLEY, P M A

    • CFA with preserved lung volumes
      1. Commentator:
        • M J DOHERTY and
        • P M A CALVERLEY
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813a

  2. Caramori, Gaetano

    • Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease Thorax 1998;53:9 803-808 doi:10.1136/thx.53.9.803

  3. Cloosterman, S G M

    • Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention Thorax 1998;53:9 768-774 doi:10.1136/thx.53.9.768

  4. Confalonieri, Marco

    • Intermediate respiratory intensive care units in Europe: a European perspective Thorax 1998;53:9 798-802 doi:10.1136/thx.53.9.798

  5. Cramer, D

    • Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis Thorax 1998;53:9 775-779 doi:10.1136/thx.53.9.775

D

  1. Dahl, Ronald

    • Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function Thorax 1998;53:9 784-789 doi:10.1136/thx.53.9.784

  2. DOHERTY, M J

    • CFA with preserved lung volumes
      1. Commentator:
        • M J DOHERTY and
        • P M A CALVERLEY
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813a

E

  1. Edgeworth, J

    • Reactivation of coccidioidomycosis in a fit American visitor Thorax 1998;53:9 811-812 doi:10.1136/thx.53.9.811

  2. ELLIOTT, M W

    • Respiratory intensive care in Europe: lessons for the UK Thorax 1998;53:9 725-726 doi:10.1136/thx.53.9.725

  3. Ennis, M

    • Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol Thorax 1998;53:9 738-743 doi:10.1136/thx.53.9.738

F

  1. Fabbri, Leonardo

    • Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease Thorax 1998;53:9 803-808 doi:10.1136/thx.53.9.803

  2. Faul, John L

    • Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time Thorax 1998;53:9 753-761 doi:10.1136/thx.53.9.753

  3. FERRER, MONTSE

    • Comparison of outcome measures in patients with COPD
      1. Commentator:
        • ROSEMARY HARPER,
        • JOHN BRAZIER,
        • and JUDITH WATERHOUSE
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813

  4. Flannery, Erin M

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  5. Folgering, H Th M

    • Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention Thorax 1998;53:9 768-774 doi:10.1136/thx.53.9.768

  6. Frederiksen, Ruben

    • Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function Thorax 1998;53:9 784-789 doi:10.1136/thx.53.9.784

  7. FRENCH, D J

    • Quality of life in cystic fibrosis Thorax 1998;53:9 721-722 doi:10.1136/thx.53.9.721

G

  1. Gannon, P F G

    • Effect of the number of peak expiratory flow readings per day on the estimation of diurnal variation Thorax 1998;53:9 790-792 doi:10.1136/thx.53.9.790

  2. Gebert, N

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

  3. GHALAUT, P S

    • Serum adenosine deaminase activity in pleural effusion Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813b

H

  1. Hancox, Bob

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  2. HARPER, ROSEMARY

    • Comparison of outcome measures in patients with COPD
      1. Commentator:
        • ROSEMARY HARPER,
        • JOHN BRAZIER,
        • and JUDITH WATERHOUSE
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813

  3. Harré, Elizabeth

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  4. Heaney, L G

    • Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol Thorax 1998;53:9 738-743 doi:10.1136/thx.53.9.738

  5. Herbison, G Peter

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  6. Hofland, I D

    • Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention Thorax 1998;53:9 768-774 doi:10.1136/thx.53.9.768

  7. HUGHES, J M B

    • CFA with preserved lung volumes
      1. Commentator:
        • M J DOHERTY and
        • P M A CALVERLEY
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813a

J

  1. JANMEJA, ASHOK

    • Serum adenosine deaminase activity in pleural effusion Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813b

  2. Jardine, Elspeth

    • Core guidelines for the discharge home of the child on long term assisted ventilation in the United Kingdom Thorax 1998;53:9 762-767 doi:10.1136/thx.53.9.762

  3. Jensen, Erik Juel

    • Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function Thorax 1998;53:9 784-789 doi:10.1136/thx.53.9.784

  4. Johnston, B T

    • Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol Thorax 1998;53:9 738-743 doi:10.1136/thx.53.9.738

K

  1. Keller, K M

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

  2. KHARB, SIMMI

    • Serum adenosine deaminase activity in pleural effusion Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813b

  3. Kharitonov, S A

    • Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis Thorax 1998;53:9 775-779 doi:10.1136/thx.53.9.775

L

  1. Lafond, Chantal

    • Influence of nasal obstruction on auto-CPAP behaviour during sleep in sleep apnoea/hypopnoea syndrome Thorax 1998;53:9 780-783 doi:10.1136/thx.53.9.780

  2. Laubscher, Keith

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  3. Lawson, J T

    • Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol Thorax 1998;53:9 738-743 doi:10.1136/thx.53.9.738

  4. Leonard, Colm T

    • Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time Thorax 1998;53:9 753-761 doi:10.1136/thx.53.9.753

  5. Linscott, Vivienne

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  6. Loukides, S

    • Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis Thorax 1998;53:9 775-779 doi:10.1136/thx.53.9.775

M

  1. MacMahon, J

    • Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol Thorax 1998;53:9 738-743 doi:10.1136/thx.53.9.738

  2. Manabe, Toshiaki

    • Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis Thorax 1998;53:9 809-811 doi:10.1136/thx.53.9.809

  3. Markides, V

    • Reactivation of coccidioidomycosis in a fit American visitor Thorax 1998;53:9 811-812 doi:10.1136/thx.53.9.811

  4. Matsushima, Toshiharu

    • Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis Thorax 1998;53:9 809-811 doi:10.1136/thx.53.9.809

  5. McGarvey, L P A

    • Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol Thorax 1998;53:9 738-743 doi:10.1136/thx.53.9.738

N

  1. Nakajima, Masamitsu

    • Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis Thorax 1998;53:9 809-811 doi:10.1136/thx.53.9.809

  2. Nava, Stefano

    • Intermediate respiratory intensive care units in Europe: a European perspective Thorax 1998;53:9 798-802 doi:10.1136/thx.53.9.798

  3. Newton, D T

    • Effect of the number of peak expiratory flow readings per day on the estimation of diurnal variation Thorax 1998;53:9 790-792 doi:10.1136/thx.53.9.790

  4. Niki, Yoshihito

    • Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis Thorax 1998;53:9 809-811 doi:10.1136/thx.53.9.809

O

  1. O’CONNELL, FINBARR

    • Management of persistent dry cough Thorax 1998;53:9 723-724 doi:10.1136/thx.53.9.723

P

  1. Pantin, C F A

    • Effect of the number of peak expiratory flow readings per day on the estimation of diurnal variation Thorax 1998;53:9 790-792 doi:10.1136/thx.53.9.790

  2. Papi, Alberto

    • Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease Thorax 1998;53:9 803-808 doi:10.1136/thx.53.9.803

  3. Paredi, P

    • Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis Thorax 1998;53:9 775-779 doi:10.1136/thx.53.9.775

  4. Paul, K D

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

  5. Pedersen, Bente

    • Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function Thorax 1998;53:9 784-789 doi:10.1136/thx.53.9.784

  6. Poulter, Leonard W

    • Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time Thorax 1998;53:9 753-761 doi:10.1136/thx.53.9.753

  7. PRIETO, LUIS

    • Comparison of outcome measures in patients with COPD
      1. Commentator:
        • ROSEMARY HARPER,
        • JOHN BRAZIER,
        • and JUDITH WATERHOUSE
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813

R

  1. Rabsch, Peter

    • Long term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosacolonisation in patients with cystic fibrosis Thorax 1998;53:9 732-737 doi:10.1136/thx.53.9.732

  2. Rampulla, Ciro

    • Intermediate respiratory intensive care units in Europe: a European perspective Thorax 1998;53:9 798-802 doi:10.1136/thx.53.9.798

  3. Ramsay, Catriona M

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  4. Richards, Geoff

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  5. Rupprath, K

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

S

  1. Saetta, Marina

    • Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease Thorax 1998;53:9 803-808 doi:10.1136/thx.53.9.803

  2. Scally, C M

    • Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol Thorax 1998;53:9 738-743 doi:10.1136/thx.53.9.738

  3. Sériès, Frédéric

    • Influence of nasal obstruction on auto-CPAP behaviour during sleep in sleep apnoea/hypopnoea syndrome Thorax 1998;53:9 780-783 doi:10.1136/thx.53.9.780

  4. Shepherd, D R T

    • Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol Thorax 1998;53:9 738-743 doi:10.1136/thx.53.9.738

  5. SINGH, VEENA

    • Serum adenosine deaminase activity in pleural effusion Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813b

  6. Spicer, M

    • Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis Thorax 1998;53:9 775-779 doi:10.1136/thx.53.9.775

  7. Staab, D

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

  8. STRICKLAND, NICOLA

    • CFA with preserved lung volumes
      1. Commentator:
        • M J DOHERTY and
        • P M A CALVERLEY
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813a

T

  1. Taylor, D Robin

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  2. Telenti, A

    • Genetics and pulmonary medicine • 5: Genetics of drug resistant tuberculosis Thorax 1998;53:9 793-797 doi:10.1136/thx.53.9.793

  3. Tormey, Vincent J

    • Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time Thorax 1998;53:9 753-761 doi:10.1136/thx.53.9.753

  4. Town, G Ian

    • Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 1998;53:9 744-752 doi:10.1136/thx.53.9.744

  5. Trettin, M

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

V

  1. van Schayck, C P

    • Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention Thorax 1998;53:9 768-774 doi:10.1136/thx.53.9.768

  2. von der Hardt, Horst

    • Long term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosacolonisation in patients with cystic fibrosis Thorax 1998;53:9 732-737 doi:10.1136/thx.53.9.732

W

  1. Wahn, U

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

  2. Wallis, Colin

    • Core guidelines for the discharge home of the child on long term assisted ventilation in the United Kingdom Thorax 1998;53:9 762-767 doi:10.1136/thx.53.9.762

  3. Ward, S

    • Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis Thorax 1998;53:9 775-779 doi:10.1136/thx.53.9.775

  4. WATERHOUSE, JUDITH

    • Comparison of outcome measures in patients with COPD
      1. Commentator:
        • ROSEMARY HARPER,
        • JOHN BRAZIER,
        • and JUDITH WATERHOUSE
      Thorax 1998;53:9 813 doi:10.1136/thx.53.9.813

  5. Wenninger, K

    • Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998;53:9 727-731 doi:10.1136/thx.53.9.727

  6. Williams, A J

    • Reactivation of coccidioidomycosis in a fit American visitor Thorax 1998;53:9 811-812 doi:10.1136/thx.53.9.811

  7. Williams, F M K

    • Reactivation of coccidioidomycosis in a fit American visitor Thorax 1998;53:9 811-812 doi:10.1136/thx.53.9.811

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.